Skip to content

PrEP use in pregnancy doesn't raise the risk of adverse pregnancy or birth outcomes

USAID | Southern Africa. Creative Commons licence.

Users of TAF in PrEP more likely to develop high blood pressure or need statins

Shutterstock Studios HIV in View gallery

Two-thirds of countries in Latin America and the Caribbean offer PrEP

CDC Global. Creative Commons licence. Image is for illustrative purposes only.

Chinese MSM need a multi-layered approach to improve PrEP uptake and adherence

Makistock/Shutterstock.com

Top 5 HIV PrEP stories from IAS 2023

Tutatamafilm/Shutterstock.com

Thai key population-led organisations give hope for sustainable HIV financing

Wiraporn Srisuwanwattana, USAID. Creative Commons licence.

Injectable PrEP requires new testing procedures, IAS conference hears

Jason Reed at IAS 2023. Photo by Roger Pebody.

Exposure to tenofovir-based PrEP in the womb does not affect children’s bone density

Dr Linxuan Wu at IAS 2023.

Are peer approaches the 'silver bullet' for increasing PrEP uptake in low-resource settings?

Dr Kalasa Mwanda at IAS 2023. Photo by Beau Newham.